Johannes Zuber is a Senior Group Leader at the Research Institute for Molecular Pathology (IMP) and Professor at the Medical University in Vienna. He studied medicine and completed a clinical residency at the Charité in Berlin. During his postdoc (CSHL, USA) and in his own lab, he developed innovative tools for loss-of-function genetics (RNAi, CRISPR, degrons) and time-resolved transcriptomics, which he applied to identify and characterize dependencies and candidate targets in cancer and tumor-associated immune cells. He received several prestigious grants (e.g. ERC-StG, ERC-POC), has been awarded with the German Cancer Prize and elected as an EMBO member in 2022.